Inhibition of the B7-H3 immune checkpoint limits tumor growth by enhancing cytotoxic lymphocyte function

Cited by (328)

Items 201–300 of 328

1. B7-H3-targeted Radioimmunotherapy of Human Cancer
   Benjamin B. Kasten, Soldano Ferrone, Kurt R. Zinn, Donald J. Buchsbaum · 2019 · Current Medicinal Chemistry
2. Recent advances and challenges of cellular immunotherapies in lung cancer treatment
   Chengfei Yang, Yue Liu, Ziqi Huang, Sijin Liu, Xi Zhang, Quanxing Liu, Jigang Dai · 2025 · Experimental Hematology and Oncology
3. A Phase I, Open-Label, Dose Escalation Study of Enoblituzumab in Children and Young Adults with B7-H3–Expressing Relapsed or Refractory Solid Tumors
   Kenneth B. DeSantes, Kimberly A. McDowell, Paul M. Sondel, Paul R. Hutson, Rosandra Natasha Kaplan, Julie R. Park, Meenakshi G. Hegde, Crystal Lee Mackall, John M. Maris · 2025 · Cancer Research Communications
4. Neutrophils and neutrophil extracellular traps: double-edged swords in cancer pathophysiology and therapy resistance
   Yao Shen, Huijie Fang, Huiqi Xie, Siqi Zhu, Xiaoqi Wang, Shuang Liu, Jiayu Sui, Yan Juan Xu, Yunfei Bo, Junjie Zhao et al. · 2025 · Cell Communication and Signaling
5. Immune Checkpoint-Associated Locations of Diffuse Gliomas Comparing Pediatric With Adult Patients Based on Voxel-Wise Analysis
   Li Zhang, Buyi Zhang, Zhangqi Dou, Jiawei Wu, Yasaman Iranmanesh, Biao Jiang, Chongran Sun, Jianmin Zhang · 2021 · Frontiers in Immunology
6. Expression Profiles and Prognostic Value of Multiple Inhibitory Checkpoints in Head and Neck Lymphoepithelioma-Like Carcinoma
   Wen-Qing Zou, Wei-Jie Luo, Yanfen Feng, Fang Liu, Shaobo Liang, Xueliang Fang, Ye‐Lin Liang, Na Liu, Yaqin Wang, Yan‐Ping Mao · 2022 · Frontiers in Immunology
7. CD276 as a Candidate Target for Immunotherapy in Medullary Thyroid Cancer
   Kinga Hińcza, Artur Kowalik, Agnieszka Walczyk, Iwona Pałyga, Danuta Gąsior‐Perczak, Agnieszka Płusa, Janusz Kopczyński, Magdalena Chrapek, Stanisław S. Góźdź, Aldona Kowalska · 2023 · International Journal of Molecular Sciences
8. B7-H3 expression in upper tract urothelial carcinoma associates with adverse clinicopathological features and poor survival
   Yuichi Koyama, Teppei Morikawa, Yu Miyama, Jimpei Miyakawa, Taketo Kawai, Haruki Kume, Motoji Sawabe, Tetsuo Ushiku · 2020 · Pathology - Research and Practice
9. The AURKA inhibitor alters the immune microenvironment and enhances targeting B7-H3 immunotherapy in glioblastoma
   Jinqiu Liu, Yuxuan Deng, Zhuonan Pu, Yazhou Miao, Zhaonian Hao, Herui Wang, Shaodong Zhang, Hanjie Liu, Jiejun Wang, Yifan Lv et al. · 2025 · JCI Insight
10. B7-H3/CD276: Novel Immune Checkpoint and Jack of All Trades
    Brigid Larkin, Daisuke Nishizaki, Hirotaka Miyashita, Suzanna Lee, Mina Nikanjam, Ramez Nassef Eskander, Taylor J. Jensen, Sarabjot Pabla, Jeffrey M. Conroy, Paul DePietro et al. · 2025 · ImmunoTargets and Therapy
11. Palmitic acid-triggered B7H3 palmitoylation promotes immune escape
    Zejun Rao, Changsheng Huang, Qi Wu, Mao Li, Anyi Liu, Tong Zhu, Wangshuo Yang, Lanlan Yin, Shengyu Zhu, Xiaowei She et al. · 2026 · Nature Communications
12. Establishment of an Ex Vivo Tissue Culture Model for Evaluation of Antitumor Efficacy in Clear Cell Renal Cell Carcinoma
    Shanjuan Hong, Qing Yuan, Haizhui Xia, Yuan Dou, Tiantian Sun, Tian Xie, Zhiyin Zhang, Wei He, Chen Dong, Jian Guo Lu et al. · 2022 · Frontiers in Oncology
13. FLG Is a Potential Biomarker of Prognosis and Immunotherapy in Skin Cutaneous Melanoma
    Shaobo Wu, Yuxia Liang, Qijuan Zang, Zixuan Xing, Pan Yin, Ruifang Sun, Bingling Dai · 2022 · Applied Bionics and Biomechanics · Retracted
14. Pan-cancer analysis identifies proteasome 26S subunit, ATPase (PSMC) family genes, and related signatures associated with prognosis, immune profile, and therapeutic response in lung adenocarcinoma
    Hui Jia, Wen-Jin Tang, Lei Sun, Chong Wan, Yun Zhou, Shen Wei-zhong · 2023 · Frontiers in Genetics
15. Immune microenvironment dynamics of HER2 overexpressing breast cancer under dual anti-HER2 blockade
    Sofia Batalha, C. M. Gomes, Catarina Brito · 2023 · Frontiers in Immunology
16. ALMS1-IT1: A Key Player in the Novel Disulfidptosis-Related LncRNA Prognostic Signature for Head and Neck Squamous Cell Carcinoma
    Xin-Yi Sun, Mian Xiao, Min Fu, Qian Gao, Ruifeng Li, Jing Wang, Hui Li, Xi‐Yuan Ge · 2024 · Biomolecules
17. Chimeric Antigen Receptor (CAR)-T Cell Immunotherapy Against Thoracic Malignancies: Challenges and Opportunities
    Long Chen, Fukun Chen, Huatao Niu, Jindan Li, Yongzhu Pu, Conghui Yang, Yue Wang, Rong Huang, Ke Li, Yujie Lei et al. · 2022 · Frontiers in Immunology
18. Prognosis and therapeutic significance of IGF-1R-related signaling pathway gene signature in glioma
    Zhen Liu, Liangwang Yang, Wenqi Wu, Zejun Chen, Zhengxing Xie, Daoming Shi, Ning Cai, Shenghua Zhuo · 2024 · Frontiers in Cell and Developmental Biology
19. Targeting B7-H3 enhances the efficacy of neoantigen-based cancer vaccine in combination with radiotherapy
    Tao‐Wei Ke, Chia-Yi Chen, William Tzu‐Liang Chen, Yuan‐Yao Tsai, Shu‐Fen Chiang, Chi-Hsien Huang, Yusen Eason Lin, Te-Hong Chen, Tsung-Wei Chen, Ji‐An Liang et al. · 2025 · npj Vaccines
20. PARP inhibitors accumulate B7-H3 on fibroblasts via blocking autophagic flux to potentiate immune evasion in ovarian cancer
    Tian Fang, Yu Xia, Ying Li, Sen Xu, Huayi Li, Siyuan Wang, Pu Huang, Yiyu Qian, Ping Jin, Ning Yi Jin et al. · 2025 · OncoImmunology
21. B7-H3 nanobody-based CAR T cells control multiple myeloma growth, while dual BCMA/B7-H3 CAR T cells overcome antigen escape
    Arne Van der Vreken, Fien Meeus, Chenggong Tu, Lauren van den Broecke, Vincenzo Raimondi, Rosanna Vescovini, Heleen Hanssens, Fenja Watté, Dorien Autaers, Marta Marco Aragon et al. · 2025 · Journal of Hematology & Oncology
22. Nano Delivery Strategy Opens Effective Avenues for the Treatment of Colorectal Cancer
    Qiurong Wei, Yunli Xu, Tianjiao Zhang, Shuyu Xu, Haonan Wang, Yuan Wang, Xinxin Xie, Xiaolong Liang · 2026 · Medicine Bulletin
23. Synthesis and Evaluation of Clinically Translatable Targeted Microbubbles Using a Microfluidic Device for In Vivo Ultrasound Molecular Imaging
    Rakesh Bam, Arutselvan Natarajan, Farbod Tabesh, Ramasamy Paulmurugan, Jeremy Dahl · 2023 · International Journal of Molecular Sciences
24. Knockout cancer by nano-delivered immunotherapy using perfusion-aided scaffold-based tumor-on-a-chip
    Pooja Suryavanshi, Dhananjay Bodas · 2024 · Nanotheranostics
25. Immune pathway through endometriosis to ovarian cancer
    Mariana Santos Calmon, Fabian Fellipe Bueno Lemos, Marcel Silva Luz, Samuel Luca Rocha Pinheiro, Luis Guilherme de Oliveira Silva, Gabriel Lima Correa Santos, Gabriel Reis Rocha, Fabrício Freire de Melo · 2024 · World Journal of Clinical Oncology
26. Future of Immune Checkpoint Inhibitors
    Ali A. Maawy, Fumito Ito · 2018 · Elsevier eBooks
27. The Prognostic Value of the Prognostic Nutritional Index in Operable High-Grade Glioma Patients and the Establishment of a Nomogram
    Qian He, Wei Zhao, Qinglan Ren · 2022 · Frontiers in Oncology
28. Deficiency of tumor-expressed B7-H3 augments anti-tumor efficacy of anti-PD-L1 monotherapy rather than the combined chemoimmunotherapy in ovarian cancer
    Mingyan Huang, Jianhua Luo, Xinpei Ji, Miao Hu, Yiquan Xue, Qiuyan Liu · 2022 · Pharmacological Research
29. Interplay between B7–H3 and HLA class I in the clinical course of pancreatic ductal adenocarcinoma
    Giulia Cattaneo, Marco Ventin, Shahrzad Arya, Filippos Kontos, Theodoros P. Michelakos, Yurie Sekigami, Lei Cai, Vincenzo Villani, Francesco Sabbatino, Francine Chen et al. · 2024 · Cancer Letters
30. A Pan-Cancer Analysis of the Oncogenic Role of CD276 in Human Tumors
    Lilong Liu, Zhipeng Yao, Yiting Liu, Yang Li, Yuhong Ding, Junyi Hu, Zhenghao Liu, Pengjie Shi, Ke Chen, Zheng Liu et al. · 2024 · Genes
31. The Regulatory Effects of MicroRNAs on Tumor Immunity
    Yan Lu, Muwen Deng, Kang Wang, Yuanhong Peng, Manzhao Ouyang · 2022 · BioMed Research International
32. Recently approved and emerging monoclonal antibody immune checkpoint inhibitors for the treatment of advanced non-small cell lung cancer
    Danilo Rocco, Luigi Della Gravara, Ciro Battiloro, Giovanni Palazzolo, Cesare Gridelli · 2023 · Expert Opinion on Biological Therapy
33. Potential role of LPAR5 gene in prognosis and immunity of thyroid papillary carcinoma and pan-cancer
    Ben Zhang, Lixi Zhang, Peng Qi, Renzhu Pang, Ziming Wang, Xuyao Liu, Qi Shi, Qiang Zhang · 2023 · Scientific Reports
34. Immunotherapy for Pediatric Gliomas: CAR-T Cells Against B7H3: A Review of the Literature
    Yolanda Santiago-Vicente, Manuel de Jesús Castillejos-López, Liliana Carmona‐Aparicio, Elvia Coballase-Urrutía, Liliana Velasco‐Hidalgo, Ana María Niembro-Zúñiga, Marta Zapata‐Tarrés, Luz María Torres Espíndola · 2023 · CNS & Neurological Disorders - Drug Targets
35. Main NK cell receptors and their ligands: regulation by microRNAs
    Stefano Regis, 1 Istituto Giannina Gaslini, Genova, Italy, Fabio Caliendo, Alessandra Dondero, Francesca Bellora, Beatrice Casu, Cristina Bottino, Roberta Castriconi · 2018 · AIMS Allergy and Immunology
36. Consensus transcriptional states describe human mononuclear phagocyte diversity in the lung across health and disease
    Joshua M. Peters, Paul C. Blainey, Bryan D. Bryson · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
37. Immune checkpoint inhibition in breast cancer: targeting PD-1/PD-L1 pathway for therapeutic advances
    Yunjin Shin, Kibeom Shin, Sihyeon Lee, Yena Son, Inmoo Rhee · 2025 · Breast Cancer
38. B7 Family Members in Pancreatic Ductal Adenocarcinoma: Attractive Targets for Cancer Immunotherapy
    Xin Chen, Jie Li, Yue Chen, Ziting Que, Jiawei Du, Jianqiong Zhang · 2022 · International Journal of Molecular Sciences
39. Development of a Human B7-H3-Specific Antibody with Activity against Colorectal Cancer Cells through a Synthetic Nanobody Library
    Jingxian Li, Bingjie Zhou, Shiting Wang, Jiayi Ouyang, Xinyi Jiang, Chenglin Wang, Teng Zhou, Ke‐wei Zheng, Junqing Wang, Jiaqi Wang · 2024 · Bioengineering
40. Mouse colorectal cancer organoids: Lessons from syngeneic and orthotopic transplantation systems
    Yu Muta, Yuki Nakanishi · 2025 · European Journal of Cell Biology
41. Protein Kinase C Isozymes Associated With Relapse Free Survival in Non-Small Cell Lung Cancer Patients
    Ann Rita Halvorsen, Mads Haugland Haugen, Åsa Kristina Öjlert, Marius Lund‐Iversen, Lars Hilmar Jørgensen, Steinar Kristian Solberg, Gunhild Mari Mælandsmo, Odd Terje Brustugun, Åslaug Helland · 2020 · Frontiers in Oncology
42. B7‐H3 drives immunosuppression and Co‐targeting with CD47 is a new therapeutic strategy in β‐catenin activated melanomas
    Min Hsu, Tiphaine C. Martin, Nikki S. Vyas, Garrett T. Desman, Karen Mendelson, Basil A. J. Horst, Ramon E. Parsons, Julide Tok Celebi · 2023 · Pigment Cell & Melanoma Research
43. From tumor immunity to precision medicine: the next step in B7-H3/CD276 research
    Haolie Fang, Yuqian Liu, Gege Wang, Heng-Jia Liu · 2025 · Medical Review
44. mTOR ‐mediated upregulation of B7 ‐ H3 in MiT / TFE translocation renal cell carcinoma
    Huili Li, Adrianna Amaral, Thiago Vidotto, Juhyung Woo, Hans B. Liu, Lia D Oliveira, Oluwademilade Dairo, Kewen Feng, Eugene Shenderov, Pedram Argani et al. · 2025 · The Journal of Pathology
45. Fully human anti-B7-H3 recombinant antibodies inhibited tumor growth by increasing T cell infiltration
    Lin Li, Siji Nian, Qin Liu, Bo Zhang, Wulemo Jimu, Chengwen Li, Zhanwen Huang, Qiaosen Hu, Yuanshuai Huang, Qing Yuan · 2024 · International Immunopharmacology
46. The expressions and significance of B7-H3 and CTLA-4 in the clinical stages of non-small-cell lung cancer.
    Zheng Liu, Meng‐Miao Pei, Junxia Liu, Fang Shi, Ye Zhang, Dongfang Zhao, Jianming Li, Feng-Rui Guo, Jing-Jing Yan, Jiaqi Liu et al. · 2019 · Europe PMC (PubMed Central)
47. Global research trends on B7-H3 for cancer immunotherapy: A bibliometric analysis (2012-2022)
    Xiaojuan Huang, Jing Guo, Shasha Wang, Zhongkun Lin, Shufen Zhao, Wenqian Li, Yan Wang, Chunyang Zhu, Jing Lv, Wensheng Qiu · 2023 · Human Vaccines & Immunotherapeutics
48. Prognostic Value of Programmed Death Ligand-1 in Discriminating Patients With Lymph Node–Negative, p53–Wild-Type, or Low-BRCA1/2-Expression Pancreatic Ductal Adenocarcinoma
    Xianlong Chen, Yue Zhang, Shengwei Mo, Heng Ma, Zhaohui Lu, Shuangni Yu, Jie Chen · 2022 · Archives of Pathology & Laboratory Medicine
49. Inhibiting PP2A Upregulates B7-H3 Expression and Potentially Increases the Sensitivity of Malignant Meningiomas to Immunotherapy by Proteomics
    Boyi Hu, Shuyu Hao, Yazhou Miao, Yuxuan Deng, Jing Wang, Hong Wan, Shaodong Zhang, Nan Ji, Jie Feng · 2022 · Pathology & Oncology Research
50. Identification of c‐Met on Tumor Cells as a Novel Receptor for B7‐H3 Entails Implications for Cancer Cell Stemness and Targeted Therapy
    Lei Cao, Yunyun Xu, Yizhou Hu, Xue F. Huang, Fengqing Fu, Shenghua Zhan, Lili Huang, Yangyang Feng, Irene Ylivinkka, Huini Li et al. · 2025 · MedComm
51. The prognostic implications of cuproptosis‐related gene signature and the potential of PPIC as a promising biomarker in cutaneous melanoma
    Bin Zhou, Shanshan Sha, Qi Wang, Shuomin Sun, Juan Tao, Jinjin Zhu, Liyun Dong · 2024 · Pigment Cell & Melanoma Research
52. Prognostic model based on M2 macrophage-related signatures for predicting outcomes, enhancing risk stratification, and providing therapeutic insights in diffuse large B-cell lymphoma
    Baoping Guo, Ying Duan, Hong Cen · 2024 · Heliyon
53. Knocking down B7H3 expression enhances cell proliferation of SHEDs via the SHP1/AKT signal axis
    Gang Chen, Yaoyao Tu, Timothy Olukunle Aladelusi, Shiming Zhao, Jun Chen, Li Jin, Dongwang Zhu · 2020 · Biochemical and Biophysical Research Communications
54. Melphalan flufenamide inhibits osteoclastogenesis by suppressing proliferation of monocytes
    Konstantin Byrgazov, Thomas Lind, Annica J. Rasmusson, Claes R. Andersson, Ana Slipicevic, Fredrik Lehmann, Joachim Gullbo, Håkan Melhus, Rolf L. Larsson, Mårten Fryknäs · 2021 · Bone Reports
55. The role of immunotherapy sensitizers and novel immunotherapy modalities in the treatment of cancer
    Guilherme Sacchi de Camargo Correia, Yujie Zhao, Rami Manochakian, Yanyan Lou · 2024 · Frontiers in Oncology
56. Expression and clinical significance of negative costimulatory molecules B7-H1, B7-H3 and B7-H4 in the process of colorectal cancer’s evolution
    Zhichao Qiu, Jingyi Wu, Yan Wang, Fang Wang, Xiaosong Ge, Xingxiang Liu, Xiaowei Qi, Dong Hua, Yong Mao · 2018 · Translational Cancer Research
57. Phenethyl isothiocyanate modulates macrophage migration inhibitory factor and suppresses malignant phenotypes of glioblastoma cells
    Jeng-Rong Lin, Wen‐Chieh Liao, Yin-Hung Chu, Yu‐Cheng Chou, Chiung-Hui Liu · 2025 · Food & Function
58. Ubiquitination-related Gene UBTD1 Mediates Poor Prognosis of Colorectal Cancer and Affects Colorectal Cancer Cell Proliferation and Ferroptosis
    Yuzhao Jin, Luyu Liao, Lingjiao Guo, Qianping Chen, Bufu Tang, Jin Jiang, Ji Ye Zhu, Minghua Bai · 2025 · Recent Patents on Anti-Cancer Drug Discovery
59. Tumor vascular normalization by B7-H3 blockade augments T lymphocyte-mediated antitumor immunity
    Xin Dai, Boran Cao, Xinnan Liu, Wangyang Meng, Yiran Qiu, Yidan Sun, Lulu Zhang, Dan Li, Zhenyu Liu, Dan Li et al. · 2025 · European Journal of Pharmacology
60. Prevalence and Clinical Association of CD276 (B7-H3) Expression in Pleural Mesothelioma: Results From the European Thoracic Platform Mesoscape Project
    Martina Haberecker, Jan H. Rüschoff, Charitini Andriakopoulou, Steven G. Gray, Kristiaan Nackaerts, Marc E. de Perrot, Luka Brčić, Ernest Nadal, Sotirios Tsimpoukis, Luca Ampollini et al. · 2025 · JCO Precision Oncology
61. Dysregulation of chromatin organization in pediatric and adult brain tumors: oncoepigenomic contributions to tumorigenesis and cancer stem cell properties
    Seungil Paik, Francesca Maule, Marco Gallo · 2020 · Genome
62. Survival and clinicopathological significance of B7-H3 in bladder cancer: a systematic review and meta-analysis
    Haohao Sun, Fei Gao, Yuan Liu, Jianfeng Shao · 2024 · BMC Urology
63. Preclinical assessment of the efficacy of B7-H3 CAR-T in renal cell carcinoma
    Huizhong Li, Fei Wang, Haifang Zhao, Jiale Cao, Shiyuan Wang, Hongxia Li, Barbara Savoldo, Enyu Rao, Gianpietro Dotti, Hongwei Du · 2024 · Molecular Immunology
64. Metastatic melanoma: therapeutic agents in preclinical and early clinical development
    Laura Amanda Boos, Isla Leslie, James Larkin · 2020 · Expert Opinion on Investigational Drugs
65. GOLM1 as a Potential Therapeutic Target Modulates B7-H3 Secretion to Drive Ovarian Cancer Metastasis
    Junhua Guan, Yun-Peng Qin, Guiyuan Deng, Haihong Zhao · 2022 · Evidence-based Complementary and Alternative Medicine
66. SH3GL1 mediates B7-H3 recycling and enhances the immune escape in non-small cell lung cancer
    Shiping Lan, Chunling Liu · 2025 · The International Journal of Biological Markers
67. Comparative Preclinical Analysis of Anti-B7-H3 CAR-T Cells Targeting Neuroblastoma
    Dzmitry V. Lutskovich, Alexander Meleshko, Valeria M. Stepanova, Dmitri Dormeshkin, Yury P. Rubtsov · 2025 · Biomedicines
68. An engineered nanosystem for reprogramming circulating malignant cells and the tumor-immune axis
    Laiqing Yan, Jinlong Wu, Mengmin Zhou, Tao Guo, Yike Zhu, Zhongyu Wu, Bo Li, Mafei Xu, Xiaohe Ren · 2025 · Chemical Engineering Journal
69. Enhancement of B7-H3 chimeric antigen receptor-T cell efficacy via the coexistence effect of IL-7, IL-15 and CCL19 for pancreatic and lung xenograft tumors
    Q. Zhang, Zu-Chian Chiang, Huanjiao Weng, Xinyi Chen, Ningning Zhao, Cailin Yan, Yonglei Xiao, Jizhen Lin, Yunlu Xu · 2026 · Biochemical Pharmacology
70. Male-biased Yap1-Cd276/B7-H3 axis for immune evasion in medulloblastoma
    Nourhan Abdelfattah, Sivaraman Natarajan, Han Nhat Tran, Thomas K. S. Wong, Maryam Faisal, Jose Maldonado, Rachael A. McMinimy, Hannah Borland, Shu‐Hsia Chen, Hong Zhao et al. · 2026 · Cancer Cell
71. The Updated Status and Future Direction of Immunotherapy Targeting B7-H1/PD-1 in Osteosarcoma
    Mengke Fan, Lili Qi, Qi Zhang, Ling Wang · 2021 · Cancer Management and Research
72. Bridging the Scientific Gaps to Identify Effective Treatments in Adrenocortical Cancer
    Nicholas Michael, Naris Nilubol · 2022 · Cancers
73. A B7-CD28 Family-Based Signature Demonstrates Significantly Different Prognosis and Immunological Characteristics in Diffuse Gliomas
    Xiangyang Deng, Kezhu Chen, Junwei Ren, Jun Zeng, Quan Zhang, Tianwen Li, Qisheng Tang, Jianhong Zhu · 2022 · Frontiers in Molecular Biosciences
74. Bottlenecks and opportunities in immunotherapy for glioma: a narrative review
    Ying Kang Shi, Mengwan Wu, Yuyang Liu, Ling Chen, Xiuwu Bian, Chuan Shan Xu · 2022 · Journal of Bio-X Research
75. Anoikis patterns via machine learning strategy and experimental verification exhibit distinct prognostic and immune landscapes in melanoma
    Jinfang Liu, Rong Ma, Siyuan Chen, Yongxian Lai, Guangpeng Liu · 2023 · Clinical & Translational Oncology
76. Transcriptional analysis of immune modulatory genes in melanoma treated with PD-1 blockade
    Hyojin Song, Sungyoung Lee, Se‐Hoon Lee, Miso Kim, Sang Yup Lee, Sung-Soo Yoon, Hongseok Yun, Youngil Koh · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
77. Blockade of CD155 and CD276 by Monoclonal Antibodies Fosters Immune Tolerance and Promotes Stable Engraftment of iPSC-Derived Islets in Allogeneic Humanized Mice
    G. Siracusano, F. Deambrogio, V. Sordi, M. Malnati, L. Piemonti, R. Chimienti · 2025 · Transplant International
78. Integrative analysis identified the key role of LAG3 in T cell exhaustion in glioma
    Zheng Wang, Haitao Fu, Yuwei Li, Zewei Liu, Wenhua Fan, Yuqing Liu, CHUANBAO ZHANG, Jingshan Liang, Zhong Zhang, Liyun Zhong et al. · 2026 · Discover Oncology
79. Low-affinity binding of anti-B7-H3 clone MJ18 to murine B7-H3 fails to induce tumor regression
    Dominik Gulyás, Talah Nammor, Jenna K. Frizzell, Roxane R. Lavoie, Liyi Geng, Svetomir N. Markovic, Fabrice Lucien · 2026 · Scientific Reports
80. Association of Iba1-Positive Macrophages and B7-H3-Positive Tumor Cells with Tumor Growth Kinetics in WHO Grade II Meningioma: A Pilot Watch-and-Wait Cohort Study
    Eiji Ito, Masasuke Ohno, Mao Yokota, Shunichiro Kuramitsu, Toru Nagasaka, Toshiaki Inomo, Tadashi Watanabe, Mitsugu Fujita · 2026 · Cancers
81. Targeting WDR12 Unleashes T‐Cell‐Mediated Antitumor Activity in Melanoma by Destabilizing CD276
    Jie Pan, Ruimin Chang, M Zhang, Qian Dong, Guanxiong Zhang, Xiang Chen, M Chen, l Zhi-Bing Lu, Xiaowei Liang, Guo Y et al. · 2026 · Advanced Science
82. B7-H3 (CD276): an actionable therapeutic target and prognostic biomarker across human malignancies
    Dayna Smith, Anudishi Tyagi, Venkata Lokesh Battula · 2026 · Frontiers in Immunology
83. Introduction on Immune Checkpoints in Cancer
    Maryam Balibegloo, Nima Rezaei · 2023 · Springer eBooks
84. Adoptive cell therapies in thoracic malignancies: a comprehensive review
    Yago Garitaonaindía, Marta Martínez-Cutillas, Maria Uribarren, Isabel Redondo, Virginia Calvo, Roberto Serna‐Blasco, Mariano Provencio · 2025 · Clinical & Translational Oncology
85. Immunotherapy in Renal Cell Carcinoma: Modulating the Tumor Microenvironment, Overcoming Resistance Mechanisms, and Implementing Biomarker-Guided Combination Treatments
    Xiaoyi Zhang, Na Xiao, Toru Yoshino, Zizhuo Yang, Jun Chen · 2025 · AI Med
86. Antitumor Responses in the Absence of Toxicity in Solid Tumors by Targeting B7-H3 Via Chimeric Antigen Receptor T Cells
    Hongwei Du, Koichi Hirabayashi, Sarah Ahn, Nancy Porterfield Kren, Stephanie A. Montgomery, Xinhui Wang, Karthik Tiruthani, Rahul Mirlekar, Daniel E. Michaud, Kevin G. Greene et al. · 2018 · SSRN Electronic Journal
87. Revisiting colorectal cancer tumorigenesis with spatially-resolved gene expression profiling
    Jessica P Roelands, Manon van der Ploeg, Hao Dang, Jurjen J. Boonstra, James C.H. Hardwick, Lukas J.A.C. Hawinkels, Hans Morreau, Noel F.C.C. de Miranda · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
88. Ubiquitination-related regulator UBTD1 closely associated with Immune Escape and suppressed cells ferroptosis in Colorectal Carcinogenesis
    Yuzhao Jin, Qianping Chen, Bufu Tang, Wei Bo Mao, Lu Wang, Huiyin Lan, Jin Fang Jiang, Minghua Bai, Ji Ye Zhu · 2023 · Research Square
89. Significance of m 6A Methyltransferase‑Related lncRNAs in the Prognosis and Immunotherapy of Hepatocellular Carcinoma
    Lili Li, Rongrong Xie, Qichun Wei · 2021 · Research Square
90. Significance of Expression of Immunomodulatory B7 Family Members B7-H3 and B7-H4 in Epithelial Ovarian Cancer
    Heather L. MacGregor · 2020 · TSpace (University of Toronto)
91. Immunotherapy
    Francesca Del Bufalo, Franco Locatelli · 2019 · Springer eBooks
92. Establishment of a mechanism-based in vitro coculture assay for evaluating the efficacy of immune checkpoint inhibitors
    Myeong Joon Kim, Kyeong Hee Hong, Bo Ryeong Lee, Sang‐Jun Ha · 2022 · Cancer Immunology Immunotherapy
93. B7-H3 targeted CAR-T cells show highly efficient anti-tumor function against osteosarcoma both in vitro and in vitro
    Qian Zhang, Zhiqiang Zhang, Guodi Liu, Dehua Li, Zhangjie Gu, Linsong Zhang, Yingjiao Pan, Xingbing Cui, Lixin Zhang, Guoping Liu et al. · 2022 · Research Square
94. Profile of Dr. Chen Dong
    2022 · Science China Life Sciences
95. Identification of a novel immune-related gene prognostic index in pancreatic adenocarcinoma and its implication on tumor immunology
    Shujing Zhou, Xufeng Huang, Szöllősi Attila Gábor, Yi-Che Chang Chien · 2022 · Research Square
96. Natural Killer Cells - Lessons and Challenges
    Leisheng Zhang · 2023 · IntechOpen eBooks
97. Natural Killer Cell-Based Cancer Immunotherapy: From Bench to Bedside
    Li Zhang, Chang Liu · 2023 · IntechOpen eBooks
98. Analysis of Prognostic Value, Immune Escape Significance and Ferroptosis Correlation of Ubiquitination-related Genes UBTD1 in Colorectal Carcinogenesis
    Yuzhao Jin, Qianping Chen, Bufu Tang, Wei Bo Mao, Lu Wang, Huiyin Lan, Minghua Bai, Ji Ye Zhu, Jin Fang Jiang · 2023 · Research Square
99. A novel cuproptosis-related signature for predicting prognosis and immune response in gastric cancer
    Kai Liang, Duguang Li, Xiaolong Liu, Fengbin Zhou, Weixin Shi, Jin Yang · 2023 · Research Square
100. Data from B7-H3: An Attractive Target for Antibody-based Immunotherapy
     Filippos Kontos, Theodoros P. Michelakos, Tomohiro Kurokawa, Ananthan Sadagopan, Joseph Hasbrouck Schwab, Cristina Rosa Ferrone, Soldano Ferrone · 2023